Carbon to Showcase 3D Printing Innovations for Dental Labs at IDS 2025

by Medical

At IDS 2025, Carbon, a U.S.-based developer of CLIP 3D printing, will showcase its latest advancements in automation, material technology, and workflow optimization, all designed to enhance the efficiency of dental labs. The company will introduce new features in its Automatic Operation (AO) Suite and unveil Lucentra, a solution for clear aligner production. These innovations aim to improve productivity and support scalable production in the dental industry.

Stratasys and Siemens Develop 3D Printed Phantoms for Medical Imaging

by Medical

Stratasys Ltd. (NASDAQ: SSYS), a manufacturer of polymer 3D printing solutions, and Siemens Healthineers, a global provider of medical imaging technology, have introduced patient-specific 3D printed phantoms designed to enhance computed tomography (CT) imaging. Research presented at the Radiological Society of North America (RSNA) annual meeting demonstrates the accuracy of these models, which replicate human anatomy with high precision.

CAD-Ray and Zylo3D Partnership: Providing Affordable and Seamless 3D Printing Solutions for Dental Professionals

by Medical

CAD-Ray, a provider of digital dentistry solutions with over 100 years of experience in dental scanning and milling, and Zylo3D, a company founded in 2023 specializing in automated, all-in-one chairside 3D printing, have partnered to offer a comprehensive dental 3D printing solution. This new solution integrates Zylo3D’s AI-driven software with CAD-Ray’s focus on affordability.

MB Therapeutics €2 Million Seed Funding to Support Personalized Medicine Production

by Medical

MB Therapeutics, a Montpellier-based startup with over 8 years of expertise in pharmaceutical 3D printing, has secured €2 million in seed funding to develop the first pharmaceutical facility designed to provide 3D printing compatible solutions for pharmacies. This facility will help pharmacies produce personalized medicines on-site, improving precision and meeting the growing demand for individualized treatments. The funding will also enable the launch of three high-demand medicines and prepare the company for a Series A funding round in 2026.

3D Printed Models Create New Paths for Treating Herpes Simplex Virus (HSV)

by Medical

In the battle against herpes simplex virus (HSV), 3D printing technology is offering a new approach to drug development by creating models of human skin. Current antiviral drugs often fall short because they cannot replicate the complexity of human tissue. To address this, Dr. Jia Zhu from the Fred Hutch Vaccine and Infectious Disease Division, alongside biofabrication experts Dr. Ian Hayman and Dr. Tori Ellison, is using 3D printing to develop these models, enhancing the precision of virus studies.